PsyBio Therapeutics Company Top Insiders
| PSYBF Stock | USD 0.0001 0.00 0.00% |
PsyBio Therapeutics employs about 4 people. The company is managed by 5 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 0.8 employees per reported executive. Examination of PsyBio Therapeutics' management performance can provide insight into the company performance.
| Andrew Jones Insider Inventor Board |
| Ross Carmel Insider Chief Director |
PsyBio |
PsyBio Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.9829) % which means that it has lost $0.9829 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.0952) %, meaning that it generated substantial loss on money invested by shareholders. PsyBio Therapeutics' management efficiency ratios could be used to measure how well PsyBio Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.PsyBio Therapeutics Workforce Comparison
PsyBio Therapeutics Corp is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is at this time estimated at about 419. PsyBio Therapeutics maintains roughly 4.0 in number of employees contributing less than 1% to stocks in Biotechnology industry.
PsyBio Therapeutics Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. PsyBio Therapeutics Corp Price Series Summation is a cross summation of PsyBio Therapeutics price series and its benchmark/peer.
PsyBio Therapeutics Notable Stakeholders
A PsyBio Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as PsyBio Therapeutics often face trade-offs trying to please all of them. PsyBio Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting PsyBio Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Andrew Jones | Inventor Board | Profile | |
| Ross Carmel | Chief Director | Profile | |
| Noah Davis | S CFO | Profile | |
| Evan Levine | CEO CoFounder | Profile | |
| MBA MBE | Chief Officer | Profile |
About PsyBio Therapeutics Management Performance
The success or failure of an entity such as PsyBio Therapeutics Corp often depends on how effective the management is. PsyBio Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of PsyBio management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the PsyBio management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. Psybio Therapeautics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
PsyBio Therapeutics Workforce Analysis
Traditionally, organizations such as PsyBio Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare PsyBio Therapeutics within its industry.PsyBio Therapeutics Manpower Efficiency
Return on PsyBio Therapeutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 2.8M | |
| Net Loss Per Executive | 2.2M |
Complementary Tools for PsyBio Pink Sheet analysis
When running PsyBio Therapeutics' price analysis, check to measure PsyBio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PsyBio Therapeutics is operating at the current time. Most of PsyBio Therapeutics' value examination focuses on studying past and present price action to predict the probability of PsyBio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PsyBio Therapeutics' price. Additionally, you may evaluate how the addition of PsyBio Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |